An Alabama woman has filed a Xigduo lawsuit against the makers of her type-2 diabetes drug claiming that her acute renal failure was a result of taking Xigduo XR.

According to her Xigduo lawsuit, plaintiff Veronica M. began taking Xigduo in May 2015.

Xigduo is a drug that is a combination of dapagliflozin (Farxiga) and metformin. Xigduo was approved in 2014 by the U.S. Food and Drug Administration for the for the treatment of type-2 diabetes. Type-2 diabetes is a disease that affects approximately 29 million people in the United States making up over nine percent of the total U.S. population.

Many type-2 diabetes drugs have been associated with adverse side effects including Invokana and Farxiga. Xigduo, as well, has been connected with potentially devastating adverse side effects.

Veronica claims that she was encouraged by her doctor to take Xigduo to reduce her blood sugar and hemoglobin levels. She and her doctors both, the Xigduo lawsuit claims, relied on claims that were made about the safety and efficacy of the drug.

Not long after she began taking Xigduo for her type-2 diabetes, she began experiencing lightheadedness, pain and elevated renal functioning. She was admitted to the hospital in Greenville, Alabama and remained there for 4 days.

She believes that as a direct and proximate result of taking Xigduo, she experienced acute renal failure.

Veronica claims in this Xigduo lawsuit that “as a direct and proximate result of Defendants’ negligence, wrongful conduct,[she] suffered severe and permanent physical and emotional injuries.”

Additionally, the Xigduo lawsuit reads that Veronica “has endured pain and suffering, emotional distress, loss of enjoyment of life, and economic loss, including significant expenses for medical care and treatment which will continue in the future.”

Xigduo XR Adverse Side Effects

This Xigduo lawsuit alleges, as do other plaintiffs filing similar lawsuits, that Bristol-Myers Squibb hid reports of diabetic ketoacidosis in relationship with Xigduo use.

Essentially, the drug makers were required by law to report to the FDA reports of ketoacidosis, but they instead reported other, less severe symptoms like dehydration, nausea, vomiting and light headedness.

Xigduo side effects, like other drugs in the same class, include dehydration, ketoacidosis (increased ketones in the blood and urine), kidney problems, serious urinary tract infections, low blood sugar (hypoglycemia), low vitamin B12, vaginal yeast infection, yeast infection of the penis, increased fats in the blood and bladder cancer.

These side effects are listed on the medication guide for Xigduo, but plaintiffs like Veronica in her Xigduo lawsuit claim that other, more severe side effects like renal failure, were not something of which she was aware when she began taking the drug.

She is bringing forth several counts including failure to warn, negligence and willful and wanton conduct or gross negligence.

Veronica has joined her Xigduo lawsuit to the larger multidistrict litigation in New York (MDL no. 2776) against Bristol-Myers Squibb and AstraZeneca.

This Xigduo Lawsuit is Case No. 1:17-cv-05757-AJN in the United States District Court for the Southern District of New York.